Bizarre Patents
A vest or belt is integrally formed with tubular, pet receiving passageways which extend around the wearer's body and terminate in pocket-like chambers for feeding and retrieval.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6958359 | Vanadium compounds as anti-angiogenic agents Vanadium compounds for inhibiting angiogenesis useful for treating or preventing diabetic retinopathy, hemangiomas, cancers with abnormal blood vessel supply, restenosis following vascular injury, and the like. ... | 10/25/2005 |
| 6878388 | Vanadium compounds for treating proliferative cell disorders Vanadium compounds useful to prevent and/or inhibit adhesion, migration, and invasion of proliferative cells into surrounding tissue. ... | 04/12/2005 |
| 6774131 | Remedies for endothelin-induced diseases A pharmaceutical composition for therapeutically treating prostate cancer, the pharmaceutical composition containing N-[6-methoxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyri midinyl]-2-phenylethenesulfoneamide or a pharmaceutically acceptable salt thereof as the e... | 08/10/2004 |
| 6642221 | Vanadium compounds as anti-proliferative agents Vanadium compounds as anti-proliferative agents. These compounds act to disrupt mitotic and meiotic spindle formation and thus are useful to prevent cell mitosis (proliferation) and meiosis.... | 11/04/2003 |
| 6060505 | Method of treating cancer using C-26 modified bryostatin Disclosed are modified bryostatins and their use as anticancer drugs.... | 05/09/2000 |
| 5958966 | Treatment of aberrant cellular states with biomodulators Biomodulators, which regulate cellular differentiation and proliferation, as well as methods of use thereof, e.g., for treating various conditions, e.g., cancer, senescence, immunological disorders and vascular disease; for stimulating normal tissue archi... | 09/28/1999 |
| 5821236 | Tumor treatment with arabinofuranosyl purine derivatives 6-Alkoxy derivatives of Ara-G, and pharmaceutically acceptable esters thereof, are described as being useful in tumor therapy. Novel pharmaceutically acceptable esters, their preparation and pharmaceutical formulations containing them are also disclosed.... | 10/13/1998 |
| 5773425 | Antineoplastic uses of aloe products Methods for the treatment of sarcoma, carcinoma and lymphoma in an animal by administering to the animal an effective amount of a polymeric acetylated mannan derivative.... | 06/30/1998 |
| 5753203 | CD30 ligand conjugates There is disclosed a polypeptide (CD30-L) and DNA sequences, vectors and transformed host cells useful in providing CD30-L polypeptides. The CD30-L polypeptide binds to the receptor known as CD30, which is expressed on a number of cell types, among which ... | 05/19/1998 |
| 5747502 | Process for preparing benzoc!phenanthridinium derivatives, novel compounds prepared by said process, and antitumor agents The present invention relates to benzoc!phenanthridinium derivative of the general formula A: ##STR1## wherein M and N individually represent a hydroxyl or lower alkoxy group, or M and N simultaneously represent a hydrogen atom or together form a ... | 05/05/1998 |
| 5747472 | Therapeutic methods for using ARA-G derivatives 6-Alkoxy derivatives of Ara-G, and pharmaceutically acceptable esters thereof, are described as being useful in tumour therapy. Novel pharmaceutically acceptable esters, their preparation and pharmaceutical formulations containing them are also disclosed.... | 05/05/1998 |
| 5736579 | Substituted spiro compounds for the treatment of inflammation A class of substituted spiro compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula III: ##STR1## wherein n is a number selected from 0, 1 and 2; wherein R | 04/07/1998 |
| 5567720 | Pharmaceutically active agents that impede amyloid formation in vivo Dense microspheres can be extracted and purified to substantial homogeneity from mammalian brain tissue, and used in the screening of therapies for potential effectiveness in impeding the formation of amyloid fibrils associated with Alzheimer's disease an... | 10/22/1996 |
| 5514661 | Immunological activity of rhamnolipids Methods for treating various autoimmune diseases and for providing immunorestoration, by administering, to a subject in need thereof, an effective amount of a composition having, as active ingredient, one or more rhamnolipids of formula (I) ##STR1## ... | 05/07/1996 |
| 5468499 | Liposomes containing the salt of phosphoramide mustard and related compounds The present invention provides an anti cancer treatment which has an improved stability and does not produce acrolein. The invention includes dichlorodiethyl phosphoramide drugs including, for example, the cyclohexylamine salt phosphoramide mustard and is... | 11/21/1995 |
| 5466675 | Immunological activity of rhamnolipids Methods for treating various autoimmune diseases and for providing immunorestoration, by administering, to a subject in need thereof, an effective amount of a composition having, as active ingredient, one or more rhamnolipids of formula (I) ##STR1## ... | 11/14/1995 |
| 5415855 | Cosmetic composition Modified ceramides are defined, together with their synthesis and compositions comprising them for topical application to human skin, hair and nails. The modified pseudoceramides have a structure: ##STR1## and an approximate summary is that R and R | 05/16/1995 |
| 5393790 | Substituted spiro compounds for the treatment of inflammation A class of substituted spiro compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula III: ##STR1## wherein n is a number selected from 0, 1 and 2; wherein R | 02/28/1995 |
| 5112869 | Substituted 1-phenylnaphthalenes This invention concerns compounds having the structure: ##STR1## wherein each of R2, R3, R4, R5, R6, R7, R2', R3', R4', and R5', is independently... | 05/12/1992 |
| 4965352 | Anthracycline derivatives having cytostatic activity The invention relates to new anthracycline derivatives having cytostatic activity and the general formula I ##STR1## wherein R1 is a CH3 (CH2)n group with n=0 to 3, R2 is a hydrogen atom or a methyl g... | 10/23/1990 |
| 4952408 | Liposome-encapsulated vinca alkaloids and their use in combatting tumors A composition made up of a liposome-encapsulated vinca alkaloid is disclosed. This composition possesses an increased antitumor activity and a substantially lower toxicity as compared to free drug.... | 08/28/1990 |
| 4479957 | Use of vindesine in treating acute lymphatic leukemia and _other susceptible neoplasms This invention relates to a method of treating neoplasms which comprises administering to a mammal suffering from a vindesinesusceptible neoplasm selected from the group consisting of acute lymphatic leukemia, acute granulocytic leukemia, chronic myeloid ... | 10/30/1984 |
| 4246400 | Tallysomycin compounds Addition of certain amine precursor compounds to the culture medium during fermentation of a tallysomycin-producing strain of Streptoalloteichus hindustanus results in production of new tallysomycin derivatives having advantageous antimicrobial and antitu... | 01/20/1981 |
| 4246399 | Complexes of doxorubicin exhibiting enhanced stability Complexes of the formula: wherein A represents doxorubicin; wherein X represents Ca++, Mg++, Zn++, or Ni++ ; and wherein n represents one or two having enhanced stability are disclosed. The above-described compounds ... | 01/20/1981 |
| 4008240 | Xanthene and thioxanthene derivatives Novel 2,7-bis basic alkanol derivatives of xanthene and thioxanthene, their preparation and use for the prevention and inhibition of viral infections are disclosed.... | 02/15/1977 |
